English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Sharda Cropchem: Revenue growth to be in 15-20% range for FY18qrcode

May. 30, 2017

Favorites Print
Forward
May. 30, 2017
Sharda Cropchem reported a mixed set of earnings for the fourth quarter ended March 31. Year on Year revenues was up 14 percent at Rs 595 crore but profit after tax (PAT) was down 2 percent at Rs 98 crore YoY. Gross margins in Q4FY17 came in down at 38.2 percent versus 35.9 percent for the same quarter last fiscal.

Throwing more light on the earnings and the outlook going forward RV Bubna, CMD, Sharda Cropchem in an interview told that the revenue growth would be in the range of 15-20 percent for FY18.

At the end of FY17, the company had 850 registrations in the pipeline, he said.

The margin impact seen in the quarter was due to fall in euro although they are receiving a strong contribution from the European region.

The Company is engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. Its core strength lies in identifying generic molecules, preparing dossiers, seeking registrations, marketing and distributing formulations or generic active ingredients in fungicide, herbicide and insecticide segments.

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox